» Authors » Yvonne Bombard

Yvonne Bombard

Explore the profile of Yvonne Bombard including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 126
Citations 1972
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Allyse M, Agam P, Bombard Y, Feys R, Horstmann M, Kokayi A, et al.
Am J Bioeth . 2025 Feb; :1-15. PMID: 39988785
Despite considerable scientific progress and the evolution of regulatory pathways to ensure safety and efficacy, US healthcare continues to see increasing health disparities. This suggests that clinical translation in of...
2.
Clausen M, Krishnapillai S, Hirjikaka D, Kodida R, Shickh S, Reble E, et al.
Genet Med Open . 2024 Dec; 2:101814. PMID: 39669596
Purpose: Increasing demand for genomic testing coupled with genetics workforce shortages has placed unsustainable pressure on standard models of care. Digital tools can offer improved access, efficiency, and cost savings....
3.
Shickh S, Mighton C, Clausen M, Sam J, Hirjikaka D, Reble E, et al.
JCO Precis Oncol . 2024 Dec; 8:e2400407. PMID: 39666930
Purpose: Genomic sequencing (GS) is increasingly used to improve diagnoses and inform targeted therapies. GS can also be used to identify the 10% of cancer patients with an underlying hereditary...
4.
Martyn M, Lee L, Jan A, Tytherleigh R, Lynch F, Mighton C, et al.
Genet Med . 2024 Nov; 27(2):101327. PMID: 39548854
Purpose: Families of children in pediatric acute care who are offered ultrarapid genomic sequencing are making complex decisions during a high-stress period. To reduce complexity for families and clinicians, we...
5.
Mighton C, Kodida R, Shickh S, Clausen M, Reble E, Sam J, et al.
Genet Med . 2024 Nov; 27(2):101323. PMID: 39530317
Purpose: Practice is shifting toward genome-first approaches, such as opportunistic screening for secondary findings (SFs). Analysis of SFs could be extended beyond medically actionable results to include non-medically actionable monogenic...
6.
Gopalakrishnan R, Sam J, Butkowsky C, Reble E, Clausen M, Rajeziesfahani S, et al.
Public Health Genomics . 2024 Oct; 27(1):240-254. PMID: 39447549
Introduction: Hereditary cancer syndromes (HCS), such as hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome (LS), represent approximately 10% of all cancers. Along with medical burdens associated with...
7.
Goh E, Chad L, Richer J, Bombard Y, Mighton C, Agatep R, et al.
J Med Genet . 2024 Oct; 61(12):1123-1131. PMID: 39362754
Background: Advances in technology and knowledge have facilitated both an increase in the number of patient variants reported and variants reclassified. While there is currently no duty to recontact for...
8.
Uberoi D, Dalpe G, Cheung K, Kondrup E, Palmour N, Arawi T, et al.
JAMA Netw Open . 2024 Sep; 7(9):e2435355. PMID: 39325459
Importance: Governments worldwide have become increasingly cognizant of the spread of genetic discrimination (negative treatment or harm on the basis of actual or presumed genetic characteristics). Despite efforts by a...
9.
Casalino S, Mighton C, Clausen M, Frangione E, Aujla N, MacDonald G, et al.
Genet Med . 2024 Sep; 26(12):101272. PMID: 39301805
Purpose: Novel uses of genome sequencing (GS) present an opportunity for return of results to healthy individuals, prompting the need for scalable genetic counseling strategies. We evaluate the effectiveness of...
10.
Majeed S, Johnston C, Saeedi S, Mighton C, Rokoszak V, Abbasi I, et al.
Am J Hum Genet . 2024 Sep; 111(10):2079-2093. PMID: 39299240
Secondary findings (SFs) from genomic sequencing can have significant impacts on patient health, yet existing practices guiding their clinical investigation are inconsistent. We systematically reviewed existing SFs policies to identify...